Welcome to our dedicated page for RTX news (Ticker: RTX), a resource for investors and traders seeking the latest updates and insights on RTX stock.
RTX Corp (NYSE: RTX) delivers cutting-edge solutions across aerospace and defense through its Collins Aerospace, Pratt & Whitney, and Raytheon segments. This news hub provides investors and industry professionals with centralized access to official updates and market analysis.
Track critical developments including quarterly earnings, defense contract awards, and aviation technology innovations. Our curated collection ensures you stay informed about strategic partnerships, regulatory milestones, and operational advancements shaping this industrial leader.
Discover press releases covering next-generation engine developments, aerospace component innovations, and defense system upgrades. Bookmark this resource for real-time updates on RTX's position in global aviation infrastructure and national security solutions.
Raytheon Technologies (NYSE: RTX) Chairman and CEO Greg Hayes will speak at the Morgan Stanley 10th Annual Laguna Conference on September 14 at 11:45 a.m. Eastern Time. The live presentation can be viewed at www.rtx.com and will be archived for later access. Established in 2020, Raytheon Technologies combines advanced aerospace and defense systems with a focus on innovation in areas such as cybersecurity and hypersonics.
Raytheon Missiles & Defense has secured a $972 million contract for upgraded AMRAAM missiles from the U.S. Air Force. This marks the first contract for the production of the AIM-120D3 and AIM-120C8 missiles, developed under the Form, Fit, Function Refresh (F3R) program. The contract not only supplies missiles to the U.S. military but also extends production to 19 allied countries. The upgraded missiles provide enhanced capabilities against advanced threats, with successful live-fire tests already conducted in June 2022.
Raytheon Missiles & Defense has secured a $182 million contract for the National Advanced Surface-to-Air Missile System (NASAMS) to support Ukraine in defending against air threats. This adaptable mid-range air defense system is developed in collaboration with Norway’s Kongsberg Defence & Aerospace. Raytheon aims to quickly deliver these critical capabilities to Ukraine, enhancing defense against cruise missiles, aircraft, and UAVs. The NASAMS system is already in use by a dozen nations globally.
Raytheon Technologies (NYSE: RTX) has invested in VerdeGo Aero to enhance hybrid-electric propulsion technologies for advanced air mobility. As the lead investor in VerdeGo's $12 million Series A funding round, RTX Ventures aims to innovate in sustainable aviation, supporting the development of powerplants converting fuel into electric power. This collaboration with Pratt & Whitney is expected to expand VerdeGo Aero's hybrid powertrain portfolio, crucial for achieving net-zero CO2 emissions by 2050.
Raytheon Technologies Corporation (RTX) reported Q2 2022 sales of $16.3 billion, reflecting a 3% increase year-over-year. GAAP EPS from continuing operations rose 28% to $0.88, while adjusted EPS increased 13% to $1.16. Operating cash flow was $1.3 billion and free cash flow reached $807 million. The company confirmed a full-year sales outlook of $67.75 - $68.75 billion and adjusted EPS of $4.60 - $4.80. The backlog totaled $161 billion, with strong defense bookings contributing significantly.
Raytheon Technologies (NYSE: RTX) has been awarded two projects by the U.S. Department of Energy aimed at exploring hydrogen and ammonia as zero-carbon fuels for electricity generation. The first project will validate the use of hydrogen in Mitsubishi Power Aero's FT4000® gas turbine. The second project, in collaboration with the University of Connecticut, focuses on ammonia as a sustainable fuel for turbines, highlighting its advantages in storage and transportation. These initiatives reflect Raytheon's commitment to advancing sustainable energy technologies.
Raytheon Missiles & Defense and Northrop Grumman successfully conducted their second flight test of the Hypersonic Air-breathing Weapon Concept (HAWC) for the U.S. Air Force and DARPA on July 18, 2022. The test validated tactical range capabilities and demonstrated progress in scramjet technology, essential for hypersonic weapons. This advancement allows for faster target acquisition, potentially evading traditional defense systems. The partnership aims to deliver next-gen tactical missile systems, further enhancing the U.S.'s weapon capabilities in hypersonics.
Raytheon Technologies (NYSE: RTX) is set to report its second quarter 2022 earnings on July 26, 2022, before the stock market opens. A conference call will follow at 8:30 a.m. ET, available for live webcast on the company's website. Investors and analysts can download a presentation prior to the call. Raytheon Technologies, headquartered in Arlington, Virginia, is a leading aerospace and defense firm formed in 2020 from the merger of Raytheon Company and United Technologies Corporation's aerospace businesses.
Raytheon Intelligence & Space showcased its Joint All Domain Command and Control capabilities at the Valiant Shield 22 exercise, successfully collecting and distributing targeting data in a simulated military environment. The Multi-Program Testbed (RMT), using radar and electronic intelligence, demonstrated rapid data synthesis and sharing among various defense platforms. This exercise underscores Raytheon’s commitment to enhancing military operations by providing swift, accurate data solutions, potentially improving battlefield decision-making and operational readiness.
Raytheon Missiles & Defense, a unit of Raytheon Technologies (NYSE: RTX), has secured a $41 million modification to an Other Transaction Agreement from the Missile Defense Agency, raising the total value to $62 million. This funding will advance the Glide Phase Interceptor (GPI), a counter-hypersonic missile designed to intercept threats in the glide phase of flight. The project aims to leverage existing missile defense technologies, enhancing efficiency and reducing development timelines.